Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
colorectal cancer
MedTech
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Cologuard Plus represents the next generation of the company's mainstay, at-home screening test for colorectal cancer.
Conor Hale
Oct 4, 2024 12:30pm
Cash-strapped Gritstone starts search for strategic alternatives
Oct 1, 2024 10:07am
Merck's LAG-3 combo fails colorectal cancer phase 3 study
Sep 25, 2024 8:35am
ESMO: Innovent links cytokine to colorectal cancer responses
Sep 18, 2024 9:53am
Exact Sciences presents early colorectal cancer blood test data
Sep 16, 2024 11:30am
Another of NuCana's retooled chemotherapies struggles in clinic
Aug 30, 2024 7:50am
